ARCHIVES

FDA Approves Abbott’s HER-2 DNA Probe Kit.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

NCI Scientists Immunize A Healthy BMT Donor Against Myeloma

May 5, 1995

Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress

October 31, 2003

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974